My take: They wouldn't have agreed to joint venture if they didn't have high confidence in being able to distribute through Lipari. But it's not a done deal; that's what they felt compelled to affirm in the updated release, which was probably done on advice of counsel.
Look: Whatever the product, Lipari could say no. A contract isn't signed until it's signed. The regulatory uncertainty around CBD makes this particular set of products less of a slam dunk than your run-of-the-mill product offering. What I believe will happen is that Michael and his partners will take Lipari management through an educational process (about the state of the regulation, about the logic of the product naming) and Lipari will sign on because a) they'll be reassured, and b) they're surely all about making money and are surely as keen as everyone else is to get on the CBD bandwagon early.
Look: Whatever the product, Lipari could say no. A contract isn't signed until it's signed. The regulatory uncertainty around CBD makes this particular set of products less of a slam dunk than your run-of-the-mill product offering. What I believe will happen is that Michael and his partners will take Lipari management through an educational process (about the state of the regulation, about the logic of the product naming) and Lipari will sign on because a) they'll be reassured, and b) they're surely all about making money and are surely as keen as everyone else is to get on the CBD bandwagon early.
11
2
